Treatment Adherence and Related Factors Among Children with Attention-Deficit/Hyperactivity Disorder in Saudi Arabia

References

• Singh A, Yeh CJ, Verma N, Das AK. Overview of attention deficit hyperactivity disorder in young children. Health Psychol Res. 2015;3(2). doi:10.4081/hpr.2015.2115
   PubMedGoogle Scholar
• Mirza H, Roberts E, AL-Belushi M, et al. School dropout and associated factors among Omani children with attention-deficit hyperactivity disorder: a cross-sectional study. J Dev Behav Pediatr. 2018;39(2):109–115. doi:10.1097/DBP.0000000000000522
   PubMed Web of Science ®Google Scholar
• Sayal K, Prasad V, Daley D, Ford T, Coghill D. ADHD in children and young people: prevalence, care pathways, and service provision. Lancet Psychiatry. 2018;5(2):175–186. doi:10.1016/S2215-0366(17)30167-0
   PubMed Web of Science ®Google Scholar
• Mirza H, Al-Huseini S, Al-Jamoodi S, et al. Socio-Demographic and Clinical Profiles of Adult Attention Deficit Hyperactivity Disorder Patients in a University Hospital in Oman. Sultan Qaboos Univ Med J. 2022;22(2):206–211. doi:10.18295/squmj.5.2021.104
   PubMedGoogle Scholar
• Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of Attention-Deficit/Hyperactivity Disorder: a Systematic Review and Meta-analysis. Pediatrics. 2015;135(4):e994–e1001. doi:10.1542/PEDS.2014-3482
   PubMed Web of Science ®Google Scholar
• Almojarthe BM. Prevalence of attention deficit hyperactivity disorder in the Arab Gulf countries: systematic review and meta-analysis. Int J Community Med Public Health. 2023;10(2):833–841. doi:10.18203/2394-6040.IJCMPH20230247
   Google Scholar
• Alzaben FN, Sehlo MG, Alghamdi WA, et al. Prevalence of attention deficit hyperactivity disorder and comorbid psychiatric and behavioral problems among primary school students in western Saudi Arabia. Saudi Med J. 2018;39(1):52–58. doi:10.15537/smj.2018.1.21288
   PubMed Web of Science ®Google Scholar
• Attention deficit hyperactivity disorder: diagnosis and management NICE guideline; 2018. Available from: www.nice.org.uk/guidance/ng87. Accessed January 30, 2024.
   Google Scholar
• Ibrahim ESR. Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder. Hum Psychopharmacol Clin Exp. 2002;17(5):225–231. doi:10.1002/HUP.406
   PubMed Web of Science ®Google Scholar
• Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psychol Med. 1999;29(3):527–538. doi:10.1017/S0033291799008338
   PubMed Web of Science ®Google Scholar
• Emilsson M, Gustafsson PA, Öhnström G, Marteinsdottir I. Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry. 2017;26(5):559–571. doi:10.1007/s00787-016-0919-1
   PubMed Web of Science ®Google Scholar
• Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgrad Med. 2010;122(1):184–191. doi:10.3810/PGM.2010.01.2112
   PubMed Web of Science ®Google Scholar
• Sanchez RJ, Crismon ML, Barner JC, Bettinger T, Wilson JP. Assessment of Adherence Measures with Different Stimulants Among Children and Adolescents. Pharmacother J Human Pharmacol Drug Ther. 2005;25(7):909–917. doi:10.1592/PHCO.2005.25.7.909
   Google Scholar
• Brinkman WB, Sucharew H, Majcher JH, Epstein JN. Predictors of Medication Continuity in Children With ADHD. Pediatrics. 2018;141(6). doi:10.1542/peds.2017-2580
   PubMed Web of Science ®Google Scholar
• Barner JC, Khoza S, Oladapo A. ADHD medication use, adherence, persistence and cost among Texas Medicaid children. Curr Med Res Opin. 2011;27(SUPPL. 2):13–22. doi:10.1185/03007995.2011.603303
   PubMed Web of Science ®Google Scholar
• Alqahtani MMJ. How do parents view psychological assessment and intervention for their children with ADHD in Saudi Arabia? Asia Pac J Couns Psychother. 2017;8(1):41–52. doi:10.1080/21507686.2016.1260612
   Web of Science ®Google Scholar
• Ahmed R, Borst JM, Yong CW, Aslani P. Do parents of children with attention-deficit/hyperactivity disorder (ADHD) receive adequate information about the disorder and its treatments? A qualitative investigation. Patient Prefer Adherence. 2014;8:661–670. doi:10.2147/PPA.S60164
   PubMedGoogle Scholar
• Ferrin M, Taylor E. Child and caregiver issues in the treatment of attention deficit-hyperactivity disorder: education, adherence and treatment choice. Future Neurol. 2011;6(3):399–413. doi:10.2217/fnl.11.5
   Google Scholar
• Charach A, Schachar R, Schachar R. Stimulant Treatment Over Five Years: adherence, Effectiveness, and Adverse Effects. J Am Acad Child Adolesc Psychiatry. 2004;43(5):559–567. doi:10.1097/00004583-200405000-00009
   PubMed Web of Science ®Google Scholar
• Wehmeier PM, Dittmann RW, Banaschewski T. Treatment compliance or medication adherence in children and adolescents on ADHD medication in clinical practice: results from the COMPLY observational study. Atten Defic Hyperact Disord. 2015;7(2):165–174. doi:10.1007/S12402-014-0156-8
   PubMedGoogle Scholar
• Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (Mars) for the psychoses. Schizophr Res. 2000;42(3):241–247. doi:10.1016/S0920-9964(99)00130-9
   PubMed Web of Science ®Google Scholar
• Chan AHY, Horne R, Hankins M, Chisari C. The Medication Adherence Report Scale: a measurement tool for eliciting patients’ reports of nonadherence. Br J Clin Pharmacol. 2020;86(7):1281–1288. doi:10.1111/BCP.14193
   PubMed Web of Science ®Google Scholar
• Owie GO, Olotu SO, James BO. Reliability and validity of the Medication Adherence Rating Scale in a cohort of patients with schizophrenia from Nigeria. Trends Psychiatry Psychother. 2018;40(2):85–92. doi:10.1590/2237-6089-2017-0077
   PubMedGoogle Scholar
• Alsous M, Alhalaiqa F, Farha RA, Jalil MA, Mcelnay J, Horne R. Reliability and validity of Arabic translation of Medication Adherence Report Scale (Mars) and Beliefs about Medication Questionnaire (BMQ)–specific for use in children and their parents. PLoS One. 2017;12(2):e0171863. doi:10.1371/JOURNAL.PONE.0171863
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24. doi:10.1080/08870449908407311
   Web of Science ®Google Scholar
• Safavi P, Saberzadeh M, Tehrani AM. Factors associated with treatment adherence in children with attention deficit hyperactivity disorder. Indian J Psychol Med. 2019;41(3):252–257. doi:10.4103/IJPSYM.IJPSYM_456_18
   PubMedGoogle Scholar
• Biederman J, Fried R, DiSalvo M, et al. Evidence of low adherence to stimulant medication among children and youths with ADHD: an electronic health records study. Psychiatric Serv. 2019;70(10):874–880. doi:10.1176/appi.ps.201800515
   PubMed Web of Science ®Google Scholar
• Van Cleave J, Leslie LK. Approaching ADHD as a chronic condition: implications for long-term adherence. J Psychosoc Nurs Ment Health Serv. 2008;46(8):28–37. doi:10.3928/02793695-20080801-07
   PubMed Web of Science ®Google Scholar
• Safavi P, Saberzadeh M, Tehrani AM. Factors Associated with Treatment Adherence in Children with Attention Deficit Hyperactivity Disorder. Indian J Psychol Med. 2019;41(3):252–257. doi:10.4103/IJPSYM.IJPSYM_456_18
   PubMedGoogle Scholar
• Sitholey P, Agarwal V, Chamoli S. A preliminary study of factors affecting adherence to medication in clinic children with attention-deficit/hyperactivity disorder. Indian J Psychiatry. 2011;53(1):41–44. doi:10.4103/0019-5545.75561
   PubMedGoogle Scholar
• Al-Harthi H, Al-Huseini S, Al-Shukaili M, et al. Parental Attitude Towards the Prescription of Psychotropic Medications for Mental Disorders in Children in a Tertiary Care University Hospital in Oman. Sultan Qaboos Univ Med J. 2023;23(2):190–197. doi:10.18295/squmj.8.2022.049
   PubMedGoogle Scholar
• Greenhill LL, Pliszka S, Dulcan MK. Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults. J Am Acad Child Adolesc Psychiatry. 2002;41(2):26S–49S. doi:10.1097/00004583-200202001-00003
   PubMed Web of Science ®Google Scholar
• Schachter HM, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ. 2001;165(11):1475.
   PubMed Web of Science ®Google Scholar
• Brown RT, Amler RW, Freeman WS, et al. Treatment of Attention-Deficit/Hyperactivity Disorder: overview of the Evidence. Pediatrics. 2005;115(6):e749–e757. doi:10.1542/PEDS.2004-2560
   PubMed Web of Science ®Google Scholar
• Swanson J. Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement. CNS Drugs. 2003;17(2):117–131. doi:10.2165/00023210-200317020-00004
   PubMed Web of Science ®Google Scholar
• Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999;104(2):e20–e20. doi:10.1542/PEDS.104.2.E20
   PubMed Web of Science ®Google Scholar
• Wilens T, Pelham W, Stein M, et al. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2003;42(4):424–433. doi:10.1097/01.CHI.0000046814.95464.7D
   PubMed Web of Science ®Google Scholar
• Steele M. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Can J Clin Pharmacol. 2006;13(4):50–62.
   Google Scholar
• Efron D, Jarman F, Barker M. Methylphenidate Versus Dexamphetamine in Children With Attention Deficit Hyperactivity Disorder: a Double-blind, Crossover Trial. Pediatrics. 1997;100(6):e6–e6. doi:10.1542/PEDS.100.6.E6
   PubMed Web of Science ®Google Scholar
• Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A. Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry. 2004;13(1). doi:10.1007/s00787-004-1010-x
   Google Scholar